Symbol | Name | Grade | Market Cap | Country |
---|---|---|---|---|
300122.CN | Chongqing Zhifei Biological Products Co. | 72.6 | $29,245 | CN |
300347.CN | Hangzhou Tigermed Consulting Co., Ltd. C | 63.7 | $13,068 | CN |
000661.CN | Changchun High & New Technology Industry | 71.3 | $11,439 | CN |
002603.CN | Shijiazhuang Yiling Pharmaceutical Co., | 65.6 | $7,265 | CN |
002821.CN | Asymchem Laboratories (Tianjin) Co., Ltd | 84.4 | $7,130 | CN |
Symbol | Name | Grade | Market Cap | Country |
---|---|---|---|---|
600833.CN | Shanghai No. 1 Pharmacy Co. Ltd. Class A | 61.1 | $390 | CN |
300453.CN | Jiang Xi Sanxin Medtec Co Ltd Class A | 63.8 | $544 | CN |
300239.CN | Baotou Dongbao Bio-Tech Co., Ltd. Class | 67.0 | $603 | CN |
603309.CN | WELL LEAD MEDICAL CO LTD Class A | 64.3 | $734 | CN |
603998.CN | Hunan Fangsheng Pharmaceutical Co., Ltd. | 67.0 | $750 | CN |
Symbol | Name | Grade | Times* | Country |
---|---|---|---|---|
000661.CN | Changchun High & New Technology Industry | 71.3 | 18 | CN |
600566.CN | HUBEI JUMPCAN PHARMACEUTICAL CO., LTD Cl | 71.0 | 14 | CN |
002252.CN | Shanghai RAAS Blood Products Co., Ltd. C | 62.9 | 13 | CN |
300482.CN | Guangzhou Wondfo Biotech Co., Ltd. Class | 74.3 | 11 | CN |
300122.CN | Chongqing Zhifei Biological Products Co. | 72.6 | 10 | CN |
000915.CN | Shandong Wit Dyne Health Co., Ltd. Class | 77.4 | 10 | CN |
300595.CN | Ovctek China, Inc. Class A | 63.6 | 10 | CN |
600867.CN | Tonghua Dongbao Pharmaceutical Co., Ltd. | 65.7 | 10 | CN |
600750.CN | Jiangzhong Pharmaceutical Co., Ltd. Clas | 52.7 | 8 | CN |
002737.CN | Sunflower Pharmaceutical Group Co., Ltd. | 66.4 | 8 | CN |
Average Market Cap | $4,120 |
Median Market Cap | $2,201 |
Avg. 3 Mo. Dollar Vol. | $48,978,080 |
Avg. 3 Mo. Trading Vol. | 11,156,541 |
Last Rebalance Date | 12/12/2022 |
Companies Replaced | 12 |
Biggest Industry Increase | Health Care |
Biggest Industry Decrease | Health Care |
Trailing P/E Ratio (12 Mo.) | 20.2 |
Forward P/E Ratio (12 Mo.) | 28.2 |
Price/Book Ratio | 3.5 |
Avg. Revenue Chg. - 3 Yr | 92.3% |
Avg. Op. Income Chg. - 3 Yr. | 223.9% |
Avg. EPS Growth - 3 Yr. | 36.7% |
Avg. EPS Growth - 1 Yr. | 30.6% |
Avg. Operating Margin | 22.6% |
Avg. LT Debt to Total Capital | 8.5% |
Avg. Return on Equity | 19.8% |
Dividend Yield | 1% |
MarketGrader China A-Shares Health Care 30 Index | 67.05 |
China | 100.0% |